Back to Search
Start Over
P128 - Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: PHASE 1 STUDY EVALUATING LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS.
- Source :
-
Leukemia Research . 2023 Supplement, Vol. 128, pN.PAG-N.PAG. 1p. - Publication Year :
- 2023
- Subjects :
- *MYELODYSPLASTIC syndromes
*DECITABINE
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 01452126
- Volume :
- 128
- Database :
- Academic Search Index
- Journal :
- Leukemia Research
- Publication Type :
- Academic Journal
- Accession number :
- 163426207
- Full Text :
- https://doi.org/10.1016/j.leukres.2023.107263